Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

50.61 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 597
Open 50.61
Bid (Size) 51.00 (1)
Ask (Size) 52.00 (4)
Prev. Close 50.61
Today's Range 50.61 - 50.61
52wk Range 42.51 - 86.95
Shares Outstanding 78,294,139
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
-Clinical Data Due Next Week at ASH- 
Via Benzinga
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
These biotech players beat the bear market this year. 
Via The Motley Fool

Performance

YTD
-38.06%
-38.06%
1 Month
+1.83%
+1.83%
3 Month
-22.15%
-22.15%
6 Month
-31.45%
-31.45%
1 Year
-35.44%
-35.44%

More News

Read More
3 Fierce Stocks That Are Screaming Buys in December
Via The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Via The Motley Fool
Bear Market Bargain Hunting: 3 Top Stocks to Buy Before 2023
Via The Motley Fool
What 5 Analyst Ratings Have To Say About CRISPR Therapeutics
Via Benzinga
Why Shares of CRISPR Therapeutics Dropped 19.9% in October
Via The Motley Fool
Where CRISPR Therapeutics Stands With Analysts
Via Benzinga
3 Growth Stocks That Are Too Cheap to Ignore
Via The Motley Fool
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
Via Investor's Business Daily
2 Stocks Near 52-Week Highs That Could Climb Higher
Via The Motley Fool
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
Via The Motley Fool
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Via Benzinga
Where Will Editas Medicine Be in 1 Year?
Via The Motley Fool
2 Growth Stocks That Could Double in 2023
Via The Motley Fool
Crispr Therapeutics Stock: Bull vs. Bear
Via The Motley Fool
5 Top Stocks to Buy Before 2023
Via The Motley Fool
Vertex Pharmaceuticals: Buy at the High?
Via The Motley Fool
Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait a Decade
Via The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
Via The Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
Via Benzinga
3 Healthcare Stocks That Could Go Parabolic
Via The Motley Fool
Got $1,000? 2 Smart Stocks to Consider Buying Right Now
Via The Motley Fool
2 Biotech Stocks That Could Make You Richer
Via The Motley Fool
3 Top Healthcare Stocks to Buy for November
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.